Suchergebnisse - "Subklewe, Marion"

PubPharm (248)

71

Immune effector cell-associated hematotoxicity : EHA/EBMT consensus grading and best practice recommendations

enthalten in: Blood | September 7, 2023

von Rejeski, K. | Subklewe, M. | Aljurf, M. | +34

72

Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control

enthalten in: International Journal of Cancer | 2023

von Stock, S. | Klüver, A. | Fertig, L. | +4

73

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American Journal of Hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

74

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy : Roadmap from an ELN‐DAVID expert panel

enthalten in: American Journal of Hematology | 2023

von Ravandi, F. | Cloos, J. | Buccisano, F. | +14

75

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2022

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

76

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

enthalten in: Journal of hematology & oncology | 2022

von Shah, B. | Ghobadi, A. | Oluwole, O. | +27

77

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

enthalten in: Journal of hematology & oncology | 2022

von Shah, B. | Ghobadi, A. | Oluwole, O. | +27

78

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL

enthalten in: Blood | 2022

von Rejeski, K. | Wu, Z. | Blumenberg, V. | +11

79

A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma

enthalten in: Cell reports. Medicine | 2022

von Fahrmann, J. | Saini, N. | Chia-Chi, C. | +28

80

A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma

enthalten in: Cell reports. Medicine | 15 November 2022

von Fahrmann, J. | Saini, N. | Chia-Chi, C. | +28